Understanding Rheumatoid Arthritis and Its Impacts

Sep 10, 2024

Notes on Rheumatoid Arthritis Lecture

Introduction to Rheumatoid Arthritis (RA)

  • Definition: RA is a chronic, inflammatory autoimmune disorder primarily affecting the joints but can also involve other organ systems.
  • Etymology:
    • "Arthr-" refers to joints.
    • "-itis" means inflammation.
    • "Rheumatoid" stems from rheumatism, which refers to musculoskeletal illnesses.

Joint Anatomy

  • Healthy Joint Structure:
    • Consists of two bones covered with articular cartilage for smooth gliding.
  • Synovial Joint Characteristics:
    • Fibrous joint capsule connecting two bones.
    • Synovial membrane lines the capsule, produces synovial fluid, and removes debris.
    • Synovial fluid resembles the jelly-like part of a chicken egg, lubricating the joint.

Pathophysiology of RA

  • Autoimmune Trigger:
    • Interaction between genetic factors (e.g., HLA-DR1, HLA-DR4) and environmental triggers (e.g., cigarette smoke, pathogens).
    • Modification of self-antigens (e.g., IgG, type II collagen) through citrullination (conversion of arginine to citrulline).
  • Immune Response:
    • Modified proteins are recognized as non-self by immune cells, leading to an immune response.
    • Activation of CD4+ T-helper cells leads to B-cell proliferation and autoantibody production.
  • Joint Inflammation:
    • Inflammatory cytokines (e.g., interferon-γ, IL-17) recruit macrophages.
    • Increased synovial cells form a pannus, damaging cartilage and eroding bone.
    • RANKL increases osteoclast activity, leading to bone breakdown.

Antibodies in RA

  • Rheumatoid Factor (RF): IgM antibody targeting altered IgG antibodies.
  • Anti-Cyclic Citrullinated Peptide (CCP) Antibody: Targets citrullinated proteins.
  • Immune Complexes: Accumulate in synovial fluid, activate the complement system, promoting inflammation.

Extra-Articular Manifestations

  • Systemic Involvement:
    • Inflammatory cytokines affect various organs, leading to symptoms such as:
      • Fever, malaise, muscle weakness.
      • Rheumatoid nodules in skin, lungs, heart, and eyes.
      • Vasculitis leading to atherosclerosis.
      • Liver produces hepcidin, affecting serum iron levels.
      • Pulmonary fibrosis and pleural effusions.
  • Felty Syndrome: Triad of RA, splenomegaly, and granulocytopenia leading to severe infections.

Clinical Presentation

  • Joint Symptoms:
    • Affects multiple joints symmetrically (e.g., hands, feet).
    • Joints are swollen, warm, red, and painful during flares.
    • Stiffness occurs, especially in the morning or after inactivity.
  • Common Deformities:
    • Ulnar deviation of fingers.
    • Boutonniere Deformity: Flexion of proximal interphalangeal joint, hyperextension of distal interphalangeal joint.
    • Swan Neck Deformity: Hyperextension of proximal interphalangeal joint, flexion of distal interphalangeal joint.

Diagnosis and Management

  • Diagnosis:
    • Blood tests for RF and anti-CCP antibodies.
    • Imaging (X-ray) shows decreased bone density, soft tissue swelling, joint space narrowing, and erosions.
  • Long-term Management:
    • Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, hydroxychloroquine, sulfasalazine.
    • Biologic Response Modifiers: Abatacept (T-cell suppression), rituximab (B-cell suppression), TNF blockers (adalimumab, etanercept, infliximab), IL-1 (anakinra), IL-6 (tocilizumab).
    • Acute Flares Treatment: NSAIDs and short-term glucocorticoids.

Summary

  • RA is a systemic inflammatory disorder of autoimmune origin, characterized by:
    • Progressive, symmetric joint destruction, primarily in the wrists and fingers.
    • Potential effects on skin, heart, blood vessels, and lungs.
    • Elevated RF and anti-CCP antibodies.